Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients. [electronic resource]
Producer: 20100329Description: 1726-30 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Asparaginase -- administration & dosage
- Bone Marrow -- pathology
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Humans
- Idarubicin -- administration & dosage
- Ifosfamide -- administration & dosage
- Incidence
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prednisolone -- administration & dosage
- Prognosis
- Registries
- Retrospective Studies
- Rituximab
- Salvage Therapy
- Survival Analysis
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.